Philippines Is Negotiating for 178 Million Coronavirus Vaccine Doses
(Bloomberg) -- Philippine President Rodrigo Duterte pledged to keep the economy afloat amid the coronavirus pandemic as his administration raced to secure vaccines enough for most of its adult population.
“We are sinking deeper and deeper,” Duterte said in a live-streamed briefing on Monday night. “We are trying our very best to keep us afloat.” The Southeast Asian nation's gross domestic product contracted by 9.5% in 2020, the most since 1946.
The Philippines, which has the second-highest number of coronavirus infections in the region, is negotiating for 178 million coronavirus vaccine doses, enough to inoculate 92 million people, Finance Secretary Carlos Dominguez said in the same briefing.
The amount is more than the target of 148 million doses this year as it takes into account delays in order delivery, Dominguez said. The government has secured $1.4 billion of funding from multilateral agencies, he said.
About 3 million doses will arrive in February and the bulk in the third and fourth quarters, said Carlito Galvez, who leads the vaccination program. The government targets to ink more supply deals this month after signing term sheets with five manufacturers to lock in about 108 million doses, Galvez said at a televised briefing Tuesday.
China can start shipping Sinovac Biotech Ltd. vaccines that it will donate to the Philippines once the Food and Drug Administration approves the manufacturer's application for emergency use, Galvez said.
The government will prioritize health care workers and uniformed personnel this quarter, and economic frontliners such as drivers and food services personnel in the second quarter. The Philippines has more than 520,000 coronavirus cases as of February 1.
Duterte said the vaccine race has turned into a competition among the highest bidders. It's not easy for Southeast Asian nations to secure shots because they are “not as really as powerful as” the European Union, he said.
Read: Philippines to Receive 5.6 Million Vaccine Doses This Quarter
©2021 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.